{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:45:58Z","timestamp":1784735158946,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with coronavirus disease 2019 (COVID-19) occasionally develop ocular complications. We report a case of acute retinal necrosis (ARN) caused by Epstein\u2013Barr Virus (EBV) that developed in a patient who had severe acute respiratory syndrome due to SARS-CoV-2 infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 68-year-old woman complained of floaters and blurred vision in her right eye as she was receiving systemic prednisolone for COVID-19 pneumonia under isolation in our hospital. The patient visited an ophthalmologist following her discharge from the hospital and after the 2 weeks of isolation had ended. At the initial examination, her best-corrected visual acuity (BCVA) was 20\/100 in the right eye, and the eye showed moderate anterior segment inflammation and vitreous opacities. Treatment was initiated with topical 0.1% betamethasone and 1.5% levofloxacin. After 1 month, the inflammation in the right eye decreased and her BCVA improved to 20\/40. However, on day 48 from her initial visit, the inflammation in her right eye worsened and her BCVA decreased to 20\/2000 by day 80. Pars plana vitrectomy with silicone oil tamponade was performed to remove the vitreous opacities, and expanded white exudates peripherally and retinal vessels with white sheathing suggestive of acute retinal necrosis (ARN) were seen intraoperatively. Analysis of the vitreous sample revealed EBV positivity on polymerase chain reaction. The patient was diagnosed with EBV-associated ARN and treated with systemic steroids and valaciclovir. The ocular inflammation gradually decreased, and she was discharged from the hospital. However, a week later, the inflammation in the right eye markedly worsened. Despite another course of steroids, the inflammation worsened, resulting in total retinal detachment and absolute glaucoma. Because of the severe pain, the right eye was enucleated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clinicians should be aware that COVID-19 and immunosuppressive treatment can reactivate EBV in the eye.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02692-5","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T08:04:50Z","timestamp":1669795490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Acute retinal necrosis in a patient on immunosuppressive treatment for COVID-19 pneumonia: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Takeyuki","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tsujinaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahoko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"2692_CR1","doi-asserted-by":"publisher","unstructured":"Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J Ophthalmol. 2021. https:\/\/doi.org\/10.4103\/ijo.IJO_297_21.","DOI":"10.4103\/ijo.IJO_297_21"},{"key":"2692_CR2","doi-asserted-by":"publisher","unstructured":"Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022. https:\/\/doi.org\/10.1002\/jmv.27292.","DOI":"10.1002\/jmv.27292"},{"key":"2692_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/jcp.25.Suppl_6.58","volume":"6","author":"RN Sutton","year":"1972","unstructured":"Sutton RN. The EB virus in relation to infectious mononucleosis. J Clin Pathol Suppl (R Coll Pathol). 1972;6:58\u201364.","journal-title":"J Clin Pathol Suppl (R Coll Pathol)."},{"key":"2692_CR4","doi-asserted-by":"publisher","unstructured":"Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N, et al. Spectrum of Epstein\u2013Barr virus-related diseases: A pictorial review. Jpn J Radiol. 2009. https:\/\/doi.org\/10.1007\/s11604-008-0291-2.","DOI":"10.1007\/s11604-008-0291-2"},{"key":"2692_CR5","doi-asserted-by":"publisher","unstructured":"Cunningham ET, Zierhut M. Epstein\u2013Barr virus and the eye. Ocul Immunol Inflamm. 2020. https:\/\/doi.org\/10.1080\/09273948.2020.1760549.","DOI":"10.1080\/09273948.2020.1760549"},{"key":"2692_CR6","doi-asserted-by":"publisher","unstructured":"Keorochana N. A case report of Epstein\u2013Barr virus-associated retinal vasculitis: Successful treatment using only acyclovir therapy. Int Med Case Rep J. 2016. https:\/\/doi.org\/10.2147\/IMCRJ.S107089.","DOI":"10.2147\/IMCRJ.S107089"},{"key":"2692_CR7","doi-asserted-by":"publisher","unstructured":"Usui M, Sakai J. Three cases of EB virus-associated uveitis. Int Ophthalmol. 1990. https:\/\/doi.org\/10.1007\/BF00163559.","DOI":"10.1007\/BF00163559"},{"key":"2692_CR8","doi-asserted-by":"publisher","unstructured":"Danielescu C, Stanca HT, Iorga RE, Darabus DM, Potop V. The Diagnosis and treatment of fungal endophthalmitis: an update. Diagnostics (Basel). 2022. https:\/\/doi.org\/10.3390\/diagnostics12030679.","DOI":"10.3390\/diagnostics12030679"},{"key":"2692_CR9","doi-asserted-by":"publisher","unstructured":"Mashima A, Usui Y, Umazume K, Muramatsu D, Goto H. Successful treatment of necrotizing retinitis with Epstein\u2013Barr virus-positive ocular fluid by intravitreal methotrexate injection. Ocul Immunol Inflamm. 2020. https:\/\/doi.org\/10.1080\/09273948.2019.1609047.","DOI":"10.1080\/09273948.2019.1609047"},{"key":"2692_CR10","doi-asserted-by":"publisher","unstructured":"Sato T, Kitamura R, Kaburaki T, Takeuchi M. Retinitis associated with double infection of Epstein\u2013Barr virus and varicella-zoster virus: A case report. Medicine (Baltimore). 2018. https:\/\/doi.org\/10.1097\/MD.0000000000011663.","DOI":"10.1097\/MD.0000000000011663"},{"key":"2692_CR11","doi-asserted-by":"publisher","unstructured":"Schaal S, Kagan A, Wang Y, Chan CC, Kaplan HJ. Acute retinal necrosis associated with Epstein\u2013Barr virus: Immunohistopathologic confirmation. JAMA Ophthalmol. 2014. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.266.","DOI":"10.1001\/jamaophthalmol.2014.266"},{"key":"2692_CR12","doi-asserted-by":"publisher","unstructured":"Dreyfus DH. Autoimmune disease: A role for new anti-viral therapies? Autoimmun Rev. 2011. https:\/\/doi.org\/10.1016\/j.autrev.2011.08.005.","DOI":"10.1016\/j.autrev.2011.08.005"},{"key":"2692_CR13","doi-asserted-by":"publisher","unstructured":"Leung EH, Fan J, Flynn HW, Albini TA. Ocular and systemic complications of COVID-19: Impact on patients and healthcare. Clin Ophthalmol. 2022. https:\/\/doi.org\/10.2147\/OPTH.S336963.","DOI":"10.2147\/OPTH.S336963"},{"key":"2692_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16794","volume-title":"Autoimmune haemolytic anaemia associated with COVID-19 infection Br J Haematol","author":"G Lazarian","year":"2020","unstructured":"Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection Br J Haematol; 2020. https:\/\/doi.org\/10.1111\/bjh.16794."},{"key":"2692_CR15","doi-asserted-by":"publisher","unstructured":"Levraut M, Ottavi M, Lechtman S, Mondain V, Jeandel PY. Immune thrombocytopenic purpura after COVID-19 infection. Int J Lab Hematol. 2021. https:\/\/doi.org\/10.1111\/ijlh.13346.","DOI":"10.1111\/ijlh.13346"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02692-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02692-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02692-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T08:09:13Z","timestamp":1669795753000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02692-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02692-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"462"}}